Kirby Daniel Gordon — SEC Form 4 filings
SEC reporting owner CIK 2055001. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-02-12 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 30,000 shares, $55,200 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 30,000 shares @ $1.84 ($55,200) in IOVANCE BIOTHERAPEUTICS, INC., filed 2025-06-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Chief Commercial Officer | 7 | 1 leg · 30,000 sh · $55,200 | — | 16 |
Form 4 filings — Kirby Daniel Gordon
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 10,001 @ $0 · Tax withholding (F): 2,436 @ $6.40 · Option exercise (M): 10,001 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 10,000 @ $0 · Tax withholding (F): 2,435 @ $3.70 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 132,200 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 120,000 @ $0 · Tax withholding (F): 34,165 @ $3.78 · Option exercise (M): 150,000 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 39,996 @ $0 · Tax withholding (F): 16,450 @ $2.60 · Option exercise (M): 39,996 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Purchase (P): 30,000 @ $1.84 | EDGAR |
| 2025-02-12 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2055001 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →